These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12634127)

  • 21. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action.
    Rajapakse N; Silva E; Kortenkamp A
    Environ Health Perspect; 2002 Sep; 110(9):917-21. PubMed ID: 12204827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-incidence modeling: consequences of linking quantal measures of response to depletion of critical tissue targets.
    Andersen ME; Lutz RW; Liao KH; Lutz WK
    Toxicol Sci; 2006 Jan; 89(1):331-7. PubMed ID: 16237194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What role for biologically based dose-response models in estimating low-dose risk?
    Crump KS; Chen C; Chiu WA; Louis TA; Portier CJ; Subramaniam RP; White PD
    Environ Health Perspect; 2010 May; 118(5):585-8. PubMed ID: 20056564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental medicine, part one: the human burden of environmental toxins and their common health effects.
    Crinnion WJ
    Altern Med Rev; 2000 Feb; 5(1):52-63. PubMed ID: 10696119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular to pharmacologic control of osteoblast proliferation and differentiation.
    Siddhanti SR; Quarles LD
    J Cell Biochem; 1994 Jul; 55(3):310-20. PubMed ID: 7962162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical hormesis: its historical foundations as a biological hypothesis.
    Calabrese EJ; Baldwin LA
    Hum Exp Toxicol; 2000 Jan; 19(1):2-31. PubMed ID: 10745292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of retinoic acid receptors and their cognate ligands in reproduction in a context of triorganotin based endocrine disrupting chemicals.
    Macejova D; Toporova L; Brtko J
    Endocr Regul; 2016 Jul; 50(3):154-64. PubMed ID: 27560799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.
    Hudnell HK
    Neurotoxicology; 1999; 20(2-3):379-97. PubMed ID: 10385898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in EDC testing.
    J Environ Monit; 2000 Dec; 2(6):97N. PubMed ID: 11296775
    [No Abstract]   [Full Text] [Related]  

  • 30. Epigenetic mechanisms of the carcinogenic effects of xenobiotics and in vitro methods of their detection.
    Hofmanová J; Machala M; Kozubík A
    Folia Biol (Praha); 2000; 46(5):165-73. PubMed ID: 11055794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular biomarkers in the measurement of xenobiotic effects].
    Ostrosky-Wegman P; Gonsebatt ME
    Gac Med Mex; 1997; 133 Suppl 1():93-6. PubMed ID: 9504110
    [No Abstract]   [Full Text] [Related]  

  • 32. An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.
    Furtaw EJ
    Toxicol Ind Health; 2001 Jun; 17(5-10):302-14. PubMed ID: 12539877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transcriptional control by nuclear steroid hormone receptors and endocrine disruptants].
    Kato S
    Nihon Rinsho; 2000 Dec; 58(12):2439-45. PubMed ID: 11187734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity.
    Welshons WV; Thayer KA; Judy BM; Taylor JA; Curran EM; vom Saal FS
    Environ Health Perspect; 2003 Jun; 111(8):994-1006. PubMed ID: 12826473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of environmental hormones on reproduction.
    Danzo BJ
    Cell Mol Life Sci; 1998 Nov; 54(11):1249-64. PubMed ID: 9849617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental xenobiotics and nuclear receptors--interactions, effects and in vitro assessment.
    Janosek J; Hilscherová K; Bláha L; Holoubek I
    Toxicol In Vitro; 2006 Feb; 20(1):18-37. PubMed ID: 16061344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine active compounds: from biology to dose response assessment.
    Barton HA; Andersen ME
    Crit Rev Toxicol; 1998 Jul; 28(4):363-423. PubMed ID: 9711433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining and modeling known adverse outcome pathways: Domoic acid and neuronal signaling as a case study.
    Watanabe KH; Andersen ME; Basu N; Carvan MJ; Crofton KM; King KA; Suñol C; Tiffany-Castiglioni E; Schultz IR
    Environ Toxicol Chem; 2011 Jan; 30(1):9-21. PubMed ID: 20963854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New directions in incidence-dose modeling.
    Andersen ME; Dennison JE; Thomas RS; Conolly RB
    Trends Biotechnol; 2005 Mar; 23(3):122-7. PubMed ID: 15734554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular signaling network motifs provide a mechanistic basis for cellular threshold responses.
    Zhang Q; Bhattacharya S; Conolly RB; Clewell HJ; Kaminski NE; Andersen ME
    Environ Health Perspect; 2014 Dec; 122(12):1261-70. PubMed ID: 25117432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.